Overview

Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The study will compare the safety, effectiveness and tolerability of gabapentin (Neurontin) versus gabapentin enacarbil (Horizant) as treatment restless leg syndrome.
Phase:
Phase 4
Details
Lead Sponsor:
Theresa Zesiewicz
Treatments:
Gabapentin
gamma-Aminobutyric Acid